ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Ascentage Pharma Grp International (6855.HK)
Ascentage Pharma Grp International share price today, ATLAS forecast and fair value
Healthcare · Biotechnology · Hong Kong Exchanges (HKEX) · Hong Kong SAR China
HK$27.90▼ -7.43%
Prices as of Oct 27, 2026 · HKD
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Ascentage Pharma Grp International in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Ascentage Pharma Grp International
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Ascentage Pharma Grp International a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between HK$24.72 and HK$30.79; in 9 out of 10, between HK$20.35 and HK$37.41. Estimated annual volatility is 65%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- HK$11.8B
- Market cap (USD)
- $1.5B
- 52-week high
- HK$69.35
- 52-week low
- HK$27.12
- Revenue (12 months)
- CN¥643M
- Gross margin
- 93.9%
- Operating margin
- -248.9%
- Net margin
- -228.5%
- Beta
- 0.66
What this means
ATLAS does not publish a fair value for 6855.HK right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 6855.HK has traded between HK$27.12 and HK$69.35. Today it is 59.8% below that high and 3% above its low.
Its beta is 0.66: it tends to move less than the market.
About the company
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
Want to see everything about Ascentage Pharma Grp International?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Ascentage Pharma Grp International do?
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
What is the chance 6855.HK goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, 6855.HK ends the month between HK$24.72 and HK$30.79.
How big is Ascentage Pharma Grp International and what is its P/E ratio?
Ascentage Pharma Grp International's market capitalization is HK$11.8B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is 6855.HK?
ATLAS estimates annual volatility at 65%. In a typical month, half of the outcomes end between HK$24.72 and HK$30.79.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer